CD274 and diffuse large B-cell lymphoma: Amplifications of 9p24.1 (PD-L1) have been associated with poor progression-free survival (PFS) in cHL [64] and favorable event-free survival and PFS in diffuse large B-cell lymphoma (DLBCL) [65].